US Archives - Page 31 of 79 - European Medical Journal

Interruptive Alerts Boost Suicide Risk Screening

A recent clinical trial sheds light on how interruptive clinical decision support (CDS) systems can significantly enhance suicide risk assessments in healthcare settings.

Study Reveals Pediatric Inflammatory Multisystem Syndrome Trends Over Pandemic

Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS), a severe inflammatory condition linked to COVID-19, has shown decreasing severity over successive pandemic waves, according to new data from Germany.

How Air Quality Impacts Autoimmune Health

A genetic link between air pollution exposure and the risk of developing autoimmune diseases such as rheumatoid arthritis (RA), lupus, and psoriasis, has been identified in a new study.

Cardiovascular Risks in Psoriasis: Biologics Study

A recent large-scale study published in a dermatology journal provides important insights into the cardiovascular safety of biologic therapies for patients with psoriasis or psoriatic arthritis (PsA).

Study Links Post-COVID-19 to Higher Risk of ME/CFS

AN increased risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following SARS-CoV-2 infection has been highlighted in a new U.S. study.

When Is It Time to Stop Colorectal Cancer Screening?

Colorectal cancer (CRC) screening guidelines may need to be more tailored, according to new research that identifies optimal stopping ages for screening based on sex, comorbidity status, and prior screening history.

The Overlooked Role of Sleep in Cystic Fibrosis Care

New research highlights a critical yet often overlooked connection: poor sleep quality significantly increases the risk of malnutrition among adolescents with cystic fibrosis (CF).

Dynamic Frailty Trends in Systemic Sclerosis

Frailty, a dynamic and clinically significant condition, is prevalent among patients with systemic sclerosis (SSc), according to a recently published study.

Investigating The Clinical Impact of HDV Infection in HBV

In the era of tenofovir-based antiretroviral therapy (ART), HBV-coinfected people with HIV (PWH) remain at significant risk for hepatitis D virus (HDV) superinfection and liver-related mortality, according to a recent study spanning 12 years.

FDA Approves Breakthrough for KRAS-Mutated Colorectal Cancer

The U.S. Food and Drug Administration (FDA) approved a novel combination therapy for adults with KRAS G12C-mutated metastatic colorectal cancer (mCRC).